Skip to content
Menu
Home
About
Leadership
Publications
Pipeline
Allergy Immunotherapy
Cancer Immunotherapy
Opioid Vaccine
ASO1-like Adjuvant Systems
TRAC478 Vaccine Adjuvant
INI-1098 Vaccine Adjuvant
Investors
News
Careers
Contact
Home
About
Leadership
Publications
Menu
Leadership
Publications
Pipeline
Allergy Immunotherapy
Cancer Immunotherapy
Opioid Vaccine
ASO1-like Adjuvant Systems
TRAC478 Vaccine Adjuvant
INI-1098 Vaccine Adjuvant
Menu
Allergy Immunotherapy
Cancer Immunotherapy
Opioid Vaccine
ASO1-like Adjuvant Systems
TRAC478 Vaccine Adjuvant
INI-1098 Vaccine Adjuvant
Investors
News
Careers
Contact
Press Releases
September 13, 2024
Insilico Medicine and Inimmune Achieved collaboration to Revolutionize Immunotherapy with AI-Driven Drug Discovery
Read More
Read More
Publication
August 6, 2024
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1
Read More
Read More
Press Releases
July 24, 2024
Inimmune Announces First Cancer Patient Dosed in Phase 1 Clinical Study Using the Immunotherapeutic INI-4001, a Novel TLR7/8 Agonist
Read More
Read More
Publication
July 23, 2024
Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization
Read More
Read More
Articles
July 22, 2024
Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization
Read More
Read More
Press Releases
July 16, 2024
SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems
Read More
Read More
Home
About
Leadership
Publications
Pipeline
Allergy Immunotherapy
Cancer Immunotherapy
Opioid Vaccine
ASO1-like Adjuvant Systems
TRAC478 Vaccine Adjuvant
INI-1098 Vaccine Adjuvant
Investors
News
Careers
Contact
Home
About
Leadership
Publications
Pipeline
Allergy Immunotherapy
Cancer Immunotherapy
Opioid Vaccine
ASO1-like Adjuvant Systems
TRAC478 Vaccine Adjuvant
INI-1098 Vaccine Adjuvant
Investors
News
Careers
Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Accept
